Brief: CTI Biopharma Corp Announces Pricing Of Its Public Offering Of Common Stock And Preferred Stock
March 31 (Reuters) - CTI Biopharma Corp CTIC.O :
* . ANNOUNCES PRICING OF ITS PUBLIC OFFERING OF COMMON STOCK
AND
PREFERRED STOCK
* OFFERING PRICE TO PUBLIC OF SHARE OF COMMON STOCK IS $2.50
* OFFERING PRICE TO PUBLIC OF A SHARE OF SERIES X(1)
PREFERRED
STOCK IS $25,000
* GROSS PROCEEDS TO CTI FROM THIS UNDERWRITTEN PUBLIC
OFFERING ARE
EXPECTED TO BE APPROXIMATELY $50.7 MILLION
Source text for Eikon: ID:nPn4S05v7a
Further company coverage: CTIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CTI Biopharma
See all newsBrief: CTI Biopharma Cancels 2023 Annual Meeting Of Stockholders
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
U.S. STOCKS ON THE MOVE-First Citizens BancShares, Sarepta, Celsius Holdings
U.S. STOCKS ON THE MOVE-Taboola, US banks, Copper miners